Found: 64
Select item for more details and to access through your institution.
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 669, doi. 10.1007/s00432-015-2033-z
- By:
- Publication type:
- Article
Antihistamines in the treatment of taxol-induced paroxystic pain syndrome.
- Published in:
- 1993
- By:
- Publication type:
- Letter
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Theodore of Mopsuestia: Commentary on Psalms 1-81.
- Published in:
- 2007
- By:
- Publication type:
- Book Review
New Testament Greek Manuscripts: Variant Readings Arranged in Horizontal Lines against Codex Vaticanus: 1 Corinthians.
- Published in:
- 2007
- By:
- Publication type:
- Book Review
The Bible in Anthanasius of Alexandria.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
On the Creation of the Cosmos according to Moses: Introduction, Translation, and Commentary.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
Explorative Study on the Predictive and Prognostic Value of Early Complete Metabolic Response By FDG-PET–CT During Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Explorative Study on the Predictive and Prognostic Value of Early Complete Metabolic Response By FDG-PET–CT During Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
- Published in:
- Clinical Ovarian & Other Gynecologic Cancer, 2012, v. 5, n. 1, p. 2, doi. 10.1016/j.cogc.2012.04.003
- By:
- Publication type:
- Article
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study).
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 8, p. 1229, doi. 10.3390/jpm13081229
- By:
- Publication type:
- Article
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 2, p. 247, doi. 10.1007/s40257-021-00645-0
- By:
- Publication type:
- Article
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 95, doi. 10.1007/s10549-022-06543-1
- By:
- Publication type:
- Article
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 689, doi. 10.1007/s10549-021-06334-0
- By:
- Publication type:
- Article
Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 3, p. 1, doi. 10.1007/s00520-024-08407-4
- By:
- Publication type:
- Article
Management of malignant cutaneous wounds in oncologic patients.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 9, p. 7615, doi. 10.1007/s00520-022-07194-0
- By:
- Publication type:
- Article
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1247291
- By:
- Publication type:
- Article
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1247291
- By:
- Publication type:
- Article
Eusebius of Caesarea, Gospel Problems and Solutions Quaestiones ad Stephanum et Marinum.
- Published in:
- 2012
- By:
- Publication type:
- Book Review
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adjuvant radiotherapy of endometrial cancer: role of <sup>18</sup>F-FDG-PET/CT in treatment modulation.
- Published in:
- European Journal of Gynaecological Oncology, 2022, v. 43, n. 2, p. 219, doi. 10.31083/j.ejgo4302028
- By:
- Publication type:
- Article
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12506-0
- By:
- Publication type:
- Article
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-021-00377-8
- By:
- Publication type:
- Article
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 41, doi. 10.3390/cancers16010041
- By:
- Publication type:
- Article
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4852, doi. 10.3390/cancers15194852
- By:
- Publication type:
- Article
Characterization of BRCA Deficiency in Ovarian Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1530, doi. 10.3390/cancers15051530
- By:
- Publication type:
- Article
Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1898, doi. 10.3390/cancers14081898
- By:
- Publication type:
- Article
Successful Pregnancies, Births, and Children Development Following Oocyte Cryostorage in Female Cancer Patients During 25 Years of Fertility Preservation.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1429, doi. 10.3390/cancers14061429
- By:
- Publication type:
- Article
Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 1993, doi. 10.3390/cancers13091993
- By:
- Publication type:
- Article
ARID1A and CTNNB1 /β-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 950, doi. 10.3390/cancers13050950
- By:
- Publication type:
- Article
Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results.
- Published in:
- Breast Cancer Research, 2016, v. 18, p. 1, doi. 10.1186/s13058-016-0773-6
- By:
- Publication type:
- Article
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 3, p. 843, doi. 10.1007/s10549-011-1660-6
- By:
- Publication type:
- Article
Development and validation of a gene expression-based Breast Cancer Purity Score.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00730-7
- By:
- Publication type:
- Article
Corrigendum: Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.705927
- By:
- Publication type:
- Article
Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial.
- Published in:
- Breast Cancer: Targets & Therapy, 2020, v. 12, p. 243, doi. 10.2147/BCTT.S261587
- By:
- Publication type:
- Article
Electrochemotherapy of skin metastases from breast cancer: a systematic review.
- Published in:
- Clinical & Experimental Metastasis, 2021, v. 38, n. 1, p. 1, doi. 10.1007/s10585-020-10063-x
- By:
- Publication type:
- Article
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status.
- Published in:
- Journal of Ovarian Research, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13048-019-0484-6
- By:
- Publication type:
- Article
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 8, p. 1001, doi. 10.1007/s00228-015-1874-3
- By:
- Publication type:
- Article
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92774-z
- By:
- Publication type:
- Article
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach.
- Published in:
- Clinical Medicine Insights: Oncology, 2018, n. 12, p. 1, doi. 10.1177/1179554918782477
- By:
- Publication type:
- Article
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 7, p. 1241, doi. 10.3390/diagnostics13071241
- By:
- Publication type:
- Article
Relevance of ARID1A Mutations in Endometrial Carcinomas.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 592, doi. 10.3390/diagnostics12030592
- By:
- Publication type:
- Article
What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 4, p. 697, doi. 10.3390/diagnostics11040697
- By:
- Publication type:
- Article
First International Colloquium on Ancient Questions and Answers Literature.
- Published in:
- Zeitschrift für Antikes Christentum / Journal of Ancient Christianity, 2004, v. 8, n. 1, p. 193
- By:
- Publication type:
- Article
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 435, doi. 10.1007/s11523-024-01058-9
- By:
- Publication type:
- Article
Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Early <sup>18</sup>F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography May Identify a Subset of Patients With Estrogen Receptor-Positive Breast Cancer Who Will Not Respond Optimally to Preoperative Chemotherapy.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 4, p. 805, doi. 10.1002/cncr.24820
- By:
- Publication type:
- Article